Innophore

Innophore is a private, AI-driven drug and enzyme discovery platform company based in Graz, Austria. Its core innovation is the patented Catalophore technology, which uses 3D point clouds to map the functional cavities and surfaces of proteins, enabling the discovery of novel biocatalysts and drug repurposing candidates with unique properties. The company operates a B2B service and platform model, having demonstrated its capabilities in large-scale drug repurposing screenings during the COVID-19 pandemic. It is recognized as an NVIDIA Inception member and has won several industry awards for its innovative approach.

Patented Catalophore point-cloud technology that uses 3D search templates of physico-chemical features to identify novel enzymes and drug candidates based on active site or surface similarity, independent of sequence or overall structure.

Innophore competes in the crowded AI-for-drug-discovery space against companies like Schrödinger, Atomwise, and Exscientia, as well as bioinformatics tool providers. Its differentiation lies in its unique 3D point-cloud approach focused on functional site geometry rather than overall structure or sequence, a niche with fewer direct competitors.